91.28
price down icon0.68%   -0.745
 
loading

Finanzdaten der Incyte Corp-Aktie (INCY)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
12.38%
1,365.98
1,215.53 1,052.90 1,137.87 1,043.76
Cost Of Revenue
25.69%
99.00
78.77 73.19 85.99 76.63
Gross Profit
11.45%
1,266.98
1,136.76 979.71 1,051.88 967.12
Operating Expenses
35.78%
823.46
606.45 774.54 905.79 1,445.26
Benefits Costs and Expenses
34.40%
883.67
657.52 818.71 981.35 1,433.54
Costs And Expenses
34.62%
922.46
685.22 847.73 991.79 1,521.89
Operating Income/Loss
16.37%
443.52
530.31 205.17 146.09 -478.13
Income/Loss From Continuing Operations Before Tax
13.57%
482.31
558.01 234.19 156.52 -389.78
Income Tax Expense/Benefit
62.00%
58.14
153.01 75.99 50.07 54.82
Income/Loss From Continuing Operations After Tax
4.73%
424.17
405.00 158.20 106.46 -444.60
Net Income/Loss
4.73%
424.17
405.00 158.20 106.46 -444.60
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.86%
195.67
194.00 193.71 192.63 218.18
Diluted Average Shares
1.35%
201.43
198.74 198.20 195.84 218.18
Basic Earnings Per Share
3.83%
2.17
2.09 0.82 0.55 -2.04
Diluted Earnings Per Share
3.43%
2.11
2.04 0.80 0.54 -2.04
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$46.06
price up icon 0.41%
$28.99
price up icon 1.33%
$54.07
price up icon 1.61%
$90.20
price up icon 0.16%
$141.15
price up icon 1.23%
biotechnology ONC
$288.30
price up icon 0.99%
Kapitalisierung:     |  Volumen (24h):